FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
GSK, Google form first bioelectronics firm; 11 generic companies benefit from the Teva Allergan deal
This week,
Phispers brings to you the details of the bioelectronics firm formed by GSK and
Google. T
Sandoz, Mylan, Hetero, Lupin face the heat due to data manipulation at Semler
In April 2016, the US Food and Drug Administration (FDA) came
down heavily on Semler Research Center